Publication Assessment of serum level of interleukin-1b and interleukin-12 in leprosy: impact of previous Bacillus Calmitte Guerin vaccination. Sallam MA, Attia E, Soliman M. Archives of dermatological research. 2014; 306 (2) : 189-95.
Publication Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines. Attia E A S, Abdallah M, El-Khateeb E, et al. Archives of dermatological research. 2014;
Publication Sidestream dark field imaging: the evolution of real-time visualization of cutaneous microcirculation and its potential application in dermatology. Treu C, Lupi O, Bottino DA, et al. Archives of dermatological research. 2011; 303 (2) : 69-78.
Publication Correlation between beta-2-glycoprotein I gene polymorphism and anti-beta-2 glycoprotein I antibodies in patients with multibacillary leprosy. Brochado MJF, Figueiredo JFC, Mendes-Junior CT, et al. Archives of dermatological research. 2010; 302 (8) : 583-91.
Publication Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases. Goulart LR, Goulart IMB. Archives of dermatological research. 2009; 301 (2) : 123-37.
Publication Leprosy: diagnostic and control challenges for a worldwide disease. Goulart IMB, Goulart LR. Archives of dermatological research. 2008; 300 (6) : 269-90.
Publication Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size. Goulart IMB, Cardoso AM, Santos MS, et al. Archives of dermatological research. 2007; 299 (5-6) : 267-71.
Publication Differential TNFalpha mRNA regulation detected in the epidermis of leprosy patients. Teles R, Moraes M, Geraldo NT R, et al. Archives of dermatological research. 2002; 294 (8) : 355-62.
Publication Immunohistochemical study of HSP-70 in two basic leprosy groups. Aroni K, Kontochristopoulos G, Liossi A, et al. Archives of dermatological research. 1996; 288 (5-6) : 252-4.
Publication Evaluation of anti-cardiolipin antibody and its cross-reactivity in sera of patients with lepromatous leprosy. Furukawa F, Kashihara M, Imamura S, et al. Archives of dermatological research. 1986; 278 (4) : 317-9.
Publication Study on the micromorphology of Mycobacterium leprae. Burchard G D, Bierther M. Archives of dermatological research. 1985; 277 (3) : 220-4.
Publication Anti-hapten antibodies and autoantibodies in Japanese patients with lepromatous leprosy. Furukawa F, Ohshio G, Ozaki M, et al. Archives of dermatological research. 1984; 276 (3) : 195-8.
Publication Evaluation of circulating immune complexes and antinuclear antibodies in Japanese patients with leprosy. Furukawa F, Sekita K, Hamashima Y, et al. Archives of dermatological research. 1983; 275 (3) : 144-6.
Publication Associations of circulating immune complexes, clinical activity, and bacterial index in Japanese patients with leprosy. Furukawa F, Ozaki M, Imamura S, et al. Archives of dermatological research. 1982; 274 (1-2) : 185-8.
Publication Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes. Miyachi Y, Ozaki M, Uchida K, et al. Archives of dermatological research. 1982; 274 (3-4) : 363-7.
Publication HLA and infectious diseases. Vries R R, Rood J J. Archives of dermatological research. 1979; 264 (1) : 89-95.
Publication The ultrastructure of mycobacterium marinum granuloma in man. Marsch W C, Nürnberger F, Stüttgen G. Archives of dermatological research. 1978; 262 (2) : 205-17.
Publication Immunofluorescence studies across the leprosy spectrum. Faber W R, Leiker DL. Archives of dermatological research. 1978; 262 (1) : 45-53.
Publication Immunofluorescence studies in reactional leprosy with relevance to treatment. Faber W R, Leiker DL, Cormane R H. Archives of dermatological research. 1978; 261 (3) : 323-30.